Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing myeloid leukemia during a period of time
go back to main search page
Accession:CMO:0002277 term browser browse the term
Definition:The number of new cases of myeloid leukemia, a form of leukemia characterized by the increased and unregulated growth of predominantly myeloid (that is, non-lymphocytic) cells in the bone marrow and the accumulation of these cells in the bone marrow and/or blood, appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage.
Synonyms:related_synonym: myeloid leukemia incidence
 xref: MESH:D007951


GViewer not supported for the selected species.

show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        leukemia incidence/prevalence measurement 0
          myeloid leukemia incidence/prevalence measurement 0
            percentage of study population developing myeloid leukemia during a period of time 0
paths to the root